C Raby

Traumatic Brain Injury Increases β‐Amyloid Peptide 1‐42 in Cerebrospinal Fluid

C Raby, Maria Cristina Morganti-Kossmann, Thomas Kossmann et al. · Journal of Neurochemistry · 1998 · 102 citations

Traumatic Brain Injury, Beta-amyloid Peptides, Neurochemical Biomarkers +19

Traumatic Brain Injury Elevates the Alzheimer's Amyloid Peptide Aβ₄₂ in Human CSF: A Possible Role for Nerve Cell Injury

Mark R. Emmerling, Maria Cristina Morganti-Kossmann, Thomas Kossmann et al. · Annals of the New York Academy of Sciences · 2000 · 97 citations

Traumatic Brain Injury, Neurochemical Biomarkers, Neurological Injury +19

Milameline (CI-979/RU35926): A Muscarinic Receptor Agonist with Cognition-Activating Properties: Biochemical and In Vivo Characterization

Roy D. Schwarz, Michael J. Callahan, Linda L. Coughenour et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 45 citations

Design and Synthesis of m1-Selective Muscarinic Agonists:  (<i>R</i>)-(−)-(<i>Z</i>)-1-Azabicyclo[2.2.1]heptan-3-one, <i>O</i>-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI<b>-</b>1017), a Functionally m1-Selective Muscarinic Agonist

Haile Tecle, Stephen D. Barrett, David Lauffer et al. · Journal of Medicinal Chemistry · 1998 · 29 citations · Full text

Pharmacotherapy, Chemistry, Heterocycle Chemistry +19

In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832

Juan C. Jaén, Stephen D. Barrett, Mark R. Brann et al. · Life Sciences · 1995 · 21 citations

Molecular Pharmacology, Functional Selectivity, Vivo Evaluation +8